Christopher R. Stone

Array ( [id] => 7216647 [patent_doc_number] => 20050054656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => '5-HT receptor ligands and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/942346 [patent_app_country] => US [patent_app_date] => 2004-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28296 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054656.pdf [firstpage_image] =>[orig_patent_app_number] => 10942346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5194446 [patent_doc_number] => 20070082930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Pharmaceutical composition comprising a p2x7 receptor antagonist and a nonsteroidal anti-inflammatory drug' [patent_app_type] => utility [patent_app_number] => 10/572276 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9265 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082930.pdf [firstpage_image] =>[orig_patent_app_number] => 10572276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5194453 [patent_doc_number] => 20070082937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Anti cancer combinations comprising a cox-2 inhibitor' [patent_app_type] => utility [patent_app_number] => 10/572304 [patent_app_country] => US [patent_app_date] => 2004-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9181 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082937.pdf [firstpage_image] =>[orig_patent_app_number] => 10572304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083794 [patent_doc_number] => 20050049174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Method and substance for facilitating weaning, reducing morbidity and reducing mortality in cardiac surgeries involving extra-corporal circulation' [patent_app_type] => utility [patent_app_number] => 10/926973 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12159 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049174.pdf [firstpage_image] =>[orig_patent_app_number] => 10926973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5643259 [patent_doc_number] => 20060281714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Combinations of a cathepsin k inhibitor and a bisphosphonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss' [patent_app_type] => utility [patent_app_number] => 10/565453 [patent_app_country] => US [patent_app_date] => 2004-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12617 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281714.pdf [firstpage_image] =>[orig_patent_app_number] => 10565453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5063736 [patent_doc_number] => 20070225376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Medicinal Agent' [patent_app_type] => utility [patent_app_number] => 11/596051 [patent_app_country] => US [patent_app_date] => 2004-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6201 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20070225376.pdf [firstpage_image] =>[orig_patent_app_number] => 11596051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4363 [patent_doc_number] => 07816358 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-19 [patent_title] => 'Pharmaceutical formulations comprising N,N′-disubstituted piperazine compounds' [patent_app_type] => utility [patent_app_number] => 10/866100 [patent_app_country] => US [patent_app_date] => 2004-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7491 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/816/07816358.pdf [firstpage_image] =>[orig_patent_app_number] => 10866100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205593 [patent_doc_number] => 20070027075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Compositions and methods for targeted drug delivery' [patent_app_type] => utility [patent_app_number] => 10/560121 [patent_app_country] => US [patent_app_date] => 2004-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 27727 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027075.pdf [firstpage_image] =>[orig_patent_app_number] => 10560121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7027010 [patent_doc_number] => 20050020662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Inhibition of PKC to treat permability failure' [patent_app_type] => utility [patent_app_number] => 10/863114 [patent_app_country] => US [patent_app_date] => 2004-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1800 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020662.pdf [firstpage_image] =>[orig_patent_app_number] => 10863114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10553904 [patent_doc_number] => 09278097 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-08 [patent_title] => 'Prophylaxis and/or treatment of portal hypertension' [patent_app_type] => utility [patent_app_number] => 10/559694 [patent_app_country] => US [patent_app_date] => 2004-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5927 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10559694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5236045 [patent_doc_number] => 20070128201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Combined use of ecteinascidin-743 and platinum antineoplastic compounds' [patent_app_type] => utility [patent_app_number] => 10/558133 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5060 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128201.pdf [firstpage_image] =>[orig_patent_app_number] => 10558133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5624822 [patent_doc_number] => 20060263327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Method for the production of a stable injectable formulation made of difficult to dissolve antineoplastic active substances' [patent_app_type] => utility [patent_app_number] => 10/540254 [patent_app_country] => US [patent_app_date] => 2004-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2348 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263327.pdf [firstpage_image] =>[orig_patent_app_number] => 10540254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051912 [patent_doc_number] => 20070032457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Combination therapy for cancer treatment' [patent_app_type] => utility [patent_app_number] => 10/556474 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 70031 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032457.pdf [firstpage_image] =>[orig_patent_app_number] => 10556474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7329910 [patent_doc_number] => 20040254154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Prediction of changes to visual acuity from assessment of macular edema' [patent_app_type] => new [patent_app_number] => 10/841608 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11826 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254154.pdf [firstpage_image] =>[orig_patent_app_number] => 10841608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5754666 [patent_doc_number] => 20060223815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Therapeutic agents comprising an anti-angiogenic agent in combination with an src-inhibitor and their therapeutic use' [patent_app_type] => utility [patent_app_number] => 10/555389 [patent_app_country] => US [patent_app_date] => 2004-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 40017 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223815.pdf [firstpage_image] =>[orig_patent_app_number] => 10555389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688874 [patent_doc_number] => 20070105824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Methods for treating degenerative diseases/injuries' [patent_app_type] => utility [patent_app_number] => 10/554811 [patent_app_country] => US [patent_app_date] => 2004-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11664 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105824.pdf [firstpage_image] =>[orig_patent_app_number] => 10554811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7061811 [patent_doc_number] => 20050004173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Inhibitors of fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction' [patent_app_type] => utility [patent_app_number] => 10/832801 [patent_app_country] => US [patent_app_date] => 2004-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3382 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20050004173.pdf [firstpage_image] =>[orig_patent_app_number] => 10832801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089620 [patent_doc_number] => 20050009733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Compositions of a cyclooxygenase-2 selective inhibitor and a potassium ion channel modulator for the treatment of central nervous system damage' [patent_app_type] => utility [patent_app_number] => 10/828990 [patent_app_country] => US [patent_app_date] => 2004-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35622 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009733.pdf [firstpage_image] =>[orig_patent_app_number] => 10828990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276426 [patent_doc_number] => 20040235877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Novel use of tricyclic compound' [patent_app_type] => new [patent_app_number] => 10/489358 [patent_app_country] => US [patent_app_date] => 2004-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15108 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235877.pdf [firstpage_image] =>[orig_patent_app_number] => 10489358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7410044 [patent_doc_number] => 20040176329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Drugs for promoting the proliferation, differentiation and/or survival of glial cells containing cyclic phosphatidic acid' [patent_app_type] => new [patent_app_number] => 10/474026 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9894 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176329.pdf [firstpage_image] =>[orig_patent_app_number] => 10474026 [rel_patent_id] =>[rel_patent_doc_number] =>)